Menopause significantly increases the buildup of plaque in arteries that leads to heart disease, according to research published in the Journal of the American Heart Association. A 2026 study found that female mice experiencing menopause developed 1.5 to 1.7 times more arterial plaque than non-menopausal mice, even when weight, body composition, and cholesterol levels were identical. This suggests that the loss of ovarian hormones during menopause itself drives atherosclerosis development, independent of other health factors.

A new study shows that menopause significantly increases the risk of atherosclerosis, the buildup of plaque in arteries that can lead to heart disease and stroke. Researchers at Gram Research analysis found that when female mice experienced menopause (either naturally induced or surgically), they developed 1.5 to 1.7 times more arterial plaque than non-menopausal mice, even when other health factors like weight and cholesterol stayed the same. The good news: menopause didn’t prevent the body’s ability to recover blood flow to the legs after injury. This research helps explain why women’s heart disease risk jumps after menopause and suggests doctors need to study women’s health more carefully in medical research.

Key Statistics

A 2026 study in the Journal of the American Heart Association found that female mice experiencing menopause developed 1.5 to 1.7 times more atherosclerotic plaque than non-menopausal control mice, despite having similar body weight, composition, and cholesterol levels.

Research shows that both chemically-induced ovarian failure and surgical ovary removal produced similar increases in arterial plaque buildup in female mice, confirming that menopause itself, regardless of how it occurs, accelerates atherosclerosis development.

According to research reviewed by Gram, menopause did not impair the body’s ability to recover blood flow to the legs after arterial injury in mice, though it did reduce muscle oxygen levels, suggesting menopause affects how efficiently tissues use oxygen.

The Quick Take

  • What they studied: Whether menopause increases the buildup of plaque in arteries (atherosclerosis) and affects the body’s ability to recover blood flow to the legs after injury.
  • Who participated: Female laboratory mice divided into three groups: mice with normal menstrual cycles, mice with chemically-induced ovarian failure, and mice that had their ovaries surgically removed. All mice were genetically modified to develop high cholesterol and were fed a diet that promotes heart disease.
  • Key finding: Mice that went through menopause (either chemically or surgically) developed 1.5 to 1.7 times more arterial plaque than control mice, despite having similar weight, body composition, and cholesterol levels.
  • What it means for you: This research suggests that menopause itself, independent of other health factors, increases a woman’s risk of developing atherosclerosis and heart disease. Women approaching or going through menopause should be especially vigilant about heart health monitoring and may benefit from discussing preventive strategies with their doctors. However, this is animal research, so results may not directly apply to humans yet.

The Research Details

Researchers used female laboratory mice to study how menopause affects heart disease development. They created three groups of mice: one group with normal ovarian function (control), one group that experienced chemical ovarian failure using a compound called 4-VCD, and one group that had their ovaries surgically removed. All mice were genetically engineered to have high cholesterol and were fed a diet designed to promote atherosclerosis, mimicking conditions that increase heart disease risk in humans.

After confirming that the menopause models worked (by checking that uterus size decreased), the researchers induced a blockage in the leg arteries of all mice to simulate a stroke or heart attack. They then measured how well the mice’s bodies recovered blood flow to the affected legs and tested muscle strength and oxygen levels in the damaged tissue.

This approach allowed researchers to compare how menopause affects both the development of arterial plaque and the body’s ability to recover from vascular injury, which is important for understanding the full impact of menopause on heart health.

Most previous heart disease research has been conducted in male animals or humans, which means we don’t fully understand how menopause affects women’s cardiovascular health. This study is important because it directly tests whether menopause itself (not just aging or other factors) drives atherosclerosis development. By using two different menopause models (chemical and surgical), the researchers could confirm that the findings weren’t specific to one method.

This study was published in the Journal of the American Heart Association, a reputable peer-reviewed journal. The research used a controlled experimental design with multiple groups for comparison, which strengthens the reliability of findings. However, this is animal research using mice, so results may not directly translate to humans. The study did not report the exact number of mice used in each group, which limits our ability to assess statistical power. The researchers controlled for important variables like diet and genetic background, which increases confidence in the results.

What the Results Show

The most striking finding was that both menopause models (chemical and surgical) led to significantly more arterial plaque buildup compared to control mice. Specifically, mice that went through menopause developed 1.5 to 1.7 times more atherosclerotic lesions than mice with normal ovarian function. This difference was notable because the menopausal mice had similar body weight, body composition, and cholesterol levels as the control mice, suggesting that menopause itself, independent of these other factors, drives atherosclerosis development.

Interestingly, menopause did not impair the mice’s ability to recover blood flow to their legs after the researchers induced an arterial blockage. Both menopausal and control mice showed similar recovery of blood perfusion (blood flow) to the affected limbs. This suggests that while menopause increases the initial development of plaque in arteries, it doesn’t prevent the body’s natural healing mechanisms from restoring blood flow after injury.

However, the researchers did find one difference in muscle function: mice that experienced menopause had reduced oxygen levels in their leg muscles after the ischemic injury, even though blood flow recovery was similar. This suggests that menopause may affect how efficiently muscles use oxygen, even when blood flow is restored.

The study confirmed that both the chemical menopause model (4-VCD) and surgical menopause (ovariectomy) produced similar results, indicating that the findings are robust regardless of how menopause is induced. Both groups showed reduced uterus mass, confirming that ovarian failure occurred. Plantar flexor muscle function (the ability to flex the foot) was similar across all groups, suggesting that menopause doesn’t significantly impair muscle strength recovery after vascular injury. The fact that metabolic profiles and cholesterol levels remained similar across groups strengthens the conclusion that menopause itself, rather than changes in these other factors, drives the increased atherosclerosis.

This research aligns with clinical observations showing that women’s risk of heart disease and stroke increases significantly after menopause. Previous studies have suggested that estrogen loss during menopause contributes to cardiovascular disease, but most preclinical research has focused on male animals. This study fills an important gap by directly testing menopause models in female mice and confirming that menopause accelerates atherosclerosis development. The findings support the idea that future cardiovascular research should include more studies in female animals and humans to better understand sex-specific differences in heart disease risk.

This study used laboratory mice, which have different physiology than humans, so the results may not directly apply to women. The study did not measure estrogen levels or investigate the specific mechanisms by which menopause increases atherosclerosis, so we don’t know exactly how the loss of ovarian hormones drives plaque buildup. The researchers did not report the sample size for each group, making it difficult to assess whether the study had enough mice to detect all potential differences. Additionally, the mice were genetically modified and fed an artificial diet designed to promote heart disease, which may not reflect the complexity of menopause in real women with varying genetics and lifestyles.

The Bottom Line

Women approaching or in menopause should discuss cardiovascular health with their doctors and consider preventive measures such as regular exercise, heart-healthy diet, blood pressure monitoring, and cholesterol management. The strength of evidence for these recommendations is moderate, based on this animal study combined with existing clinical observations. Women should not make decisions about hormone replacement therapy based solely on this research, but should discuss all options with their healthcare provider. This research suggests that menopause itself is a cardiovascular risk factor that deserves clinical attention.

This research is most relevant to women approaching menopause, women currently in menopause, and healthcare providers who care for women. It’s also important for cardiovascular researchers who design studies, as it highlights the need to include female subjects and menopause models in heart disease research. Men should care about this research because it helps explain cardiovascular disease in their female partners, family members, and friends.

The effects of menopause on atherosclerosis development likely occur gradually over months to years, not overnight. In this study, significant plaque buildup was observed over a 23-week period in mice. In humans, the increased cardiovascular risk from menopause typically becomes apparent over several years after menopause begins. Women should expect that cardiovascular benefits from lifestyle changes (exercise, diet, stress management) may take weeks to months to become apparent, while the protective effects of preventive medications like statins may take longer.

Frequently Asked Questions

Does menopause increase the risk of heart disease and stroke in women?

Research suggests menopause significantly increases heart disease risk. A 2026 study found that menopausal female mice developed 1.5 to 1.7 times more arterial plaque than non-menopausal mice, even with identical cholesterol and weight levels, indicating menopause itself drives atherosclerosis development.

What causes the increased heart disease risk after menopause?

The loss of estrogen during menopause appears to be the primary driver, though the exact mechanisms aren’t fully understood. This study shows menopause increases plaque buildup independent of weight, cholesterol, or other metabolic factors, suggesting hormonal changes directly affect artery health.

Can the body still recover from a heart attack or stroke after menopause?

This research suggests menopause doesn’t prevent the body’s ability to restore blood flow after vascular injury. However, menopausal mice showed reduced muscle oxygen levels, indicating menopause may affect how efficiently tissues use oxygen during recovery.

Should women take hormone replacement therapy to prevent heart disease after menopause?

This animal study doesn’t directly answer that question. Women should discuss hormone replacement therapy and other preventive strategies with their doctors, considering individual risk factors, symptoms, and medical history. This research highlights that menopause itself increases cardiovascular risk and deserves clinical attention.

What can women do to reduce heart disease risk during and after menopause?

Regular exercise, heart-healthy diet, blood pressure monitoring, and cholesterol management are evidence-based strategies. This research suggests these preventive measures are especially important during menopause, when cardiovascular risk increases. Discuss personalized prevention plans with your healthcare provider.

Want to Apply This Research?

  • Track cardiovascular risk factors monthly: blood pressure readings, resting heart rate, exercise minutes per week, and dietary patterns (especially saturated fat intake). Women in menopause should also note menopause symptoms and any changes in energy or exercise tolerance, as these may correlate with cardiovascular changes.
  • Implement a structured exercise program of at least 150 minutes of moderate aerobic activity per week, combined with strength training twice weekly. Use the app to log workouts, set reminders for exercise sessions, and track improvements in endurance or strength. For women in menopause, consistent exercise may help offset some of the increased atherosclerosis risk shown in this research.
  • Establish a baseline cardiovascular health profile (blood pressure, cholesterol if available, resting heart rate) and track these metrics quarterly. Use the app to monitor trends over time and share data with healthcare providers during annual check-ups. Women in menopause should pay special attention to any new symptoms like chest discomfort, shortness of breath, or unusual fatigue, and report these immediately to their doctor.

This research was conducted in laboratory mice and may not directly apply to humans. While the findings suggest menopause increases atherosclerosis risk, individual cardiovascular risk varies based on genetics, lifestyle, and other health factors. Women should not make medical decisions based solely on this research. Consult with your healthcare provider about your personal cardiovascular risk, appropriate screening, and prevention strategies. This article is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Ovariectomy and Chemical Ovarian Failure Exacerbate Atherosclerosis Without Impairing Recovery From Hindlimb Ischemia. , Journal of the American Heart Association (2026). PubMed 42786647 | DOI
Topics
menopause and heart disease atherosclerosis in women cardiovascular risk menopause estrogen and heart health women's heart disease prevention arterial plaque buildup menopause cardiovascular health female heart disease research